Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini(Istituto di Ematologia di Bologna), Mohamad Mohty(Sorbonne Université), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Ciceri(Vita-Salute San Raffaele University), Victoria Potter(King's College Hospital NHS Foundation Trust), Patrice Chevallier(Hotel Dieu Hospital), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Friedrich Stölzel(German Cancer Research Center), Maud Ngoya, Arnon Nagler(Sheba Medical Center), Jan J. Cornelissen(Erasmus MC), Jacques‐Emmanuel Galimard(Hôpital Saint-Antoine), Eleni Tholouli(Manchester Royal Infirmary), Charles Craddock(University Hospitals Birmingham NHS Foundation Trust), Uwe Platzbecker(National Center for Tumor Diseases), Johan Maertens(Unknown), Goda Choi(University Medical Center Groningen), Samia Harbi(Centre de Recherche en Cancérologie de Marseille), Henrik Sengeloev(Rigshospitalet), Alexandros Spyridonidis(General University Hospital of Patras)
Cited by 19
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k